医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Foo.log Inc. Releases U.S. Localized Version of First Image-Recognition-Assisted Food Recording App for iOS/Android

2015年11月12日 AM01:00
このエントリーをはてなブックマークに追加


 

TOKYO

Foo.log Inc. announced that their photo-based food recording app to visualize eating habits, FoodLog : Calorie Counter, is now available in English as well as is equipped with a U.S. food database. FoodLog allows users to use an image-assisted recording where names of foods in a photo are suggested by image search through a personalized database. The app has been downloaded 78,357 times in Japan in two years.

A food image recognition engine suggests candidates of food descriptions so that a user can select correct one instead of typing its name. The engine, which was developed by Prof. Aizawa and his group in the university of Tokyo, searches through the user’s personal record to produce a list of candidates, thus, the system is fully personalized and it will become wiser as the number of record increases. Free text input is also available if the initial search fails.

FoodLog shows daily intake of calorie and summarizes monthly and yearly average along with photo tiles of dishes. “Keeping record must be pleasure,” said Masanori Kubota, operating officer of foo.log Inc. “You will find the picture tiles themselves are beautiful and valuable because they made you healthy.”

FoodLog is available world-wide on Apple’s App Store and Google Play for free. Please visit app.foodlog.jp for more FoodLog and company information, including videos and screenshots of the app.

Foo.log Inc., based in Tokyo, Japan, was formed in 2005 by Makoto Ogawa to offer ICT services in health care field based on an image analysis technology specialized in food.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151111005022/en/

CONTACT

foo.log Inc.
Msanori Kubota, 81-3-3813-7170
info@foo-log.co.jp

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • FDA Grants Priority Review for Genentech’s Actemra® (Tocilizumab) Supplemental Biologics License Application for Giant Cell Arteritis, a Form of Vasculitis
  • TL PLASTIC SURGERY in South Korea, the Best Choice for Your Satisfying Breast Augmentation Surgery
  • Ascendia Pharmaceuticals宣布其治疗急性冠脉综合征的ASD-002项目获颁一项新专利
  • 年次世界患者安全・科学・技術サミットで初めて米国外向けにHDライブストリーミングを実施へ
  • Accelsiors CRO Expands Global Footprint